Get the Stockscreener App
216.57
1.41%
-3.10
After Hours:
216.57
Overview
News
Price History
Option Chain
Financials
Why STE Down?
Discussions
Forecast
Stock Split
Dividend History
Steris Plc stock is traded at $216.57, with a volume of 637.28K.
It is down -1.41% in the last 24 hours and down -3.12% over the past month.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
See More
Previous Close:
$219.67
Open:
$219.98
24h Volume:
637.28K
Relative Volume:
0.79
Market Cap:
$21.24B
Revenue:
$5.94B
Net Income/Loss:
$785.30M
P/E Ratio:
27.30
EPS:
7.9343
Net Cash Flow:
$972.40M
1W Performance:
+2.10%
1M Performance:
-3.12%
6M Performance:
-17.74%
1Y Performance:
-11.17%
1-Day Range:
$215.32
$219.98
1-Week Range:
$209.33
$219.98
52-Week Range:
$195.14
$269.44
Steris Plc Stock (STE) Company Profile
Name
Steris Plc
Sector
Industry
Phone
35312322000
Address
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Compare STE vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STE
Steris Plc
|
216.57 | 21.54B | 5.94B | 785.30M | 972.40M | 7.9343 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-29-25 | Initiated | Jefferies | Hold |
| Oct-24-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| May-30-23 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-14-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-23-22 | Downgrade | Needham | Buy → Hold |
| Jul-14-22 | Initiated | Piper Sandler | Overweight |
| Apr-07-22 | Initiated | Wolfe Research | Outperform |
| May-26-21 | Upgrade | Needham | Hold → Buy |
| Feb-04-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-09-20 | Initiated | Needham | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-05-17 | Downgrade | Wellington Shields | Gradually Accumulate → Hold |
| May-03-17 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Nov-30-16 | Initiated | Goldman | Neutral |
| Jun-03-16 | Upgrade | Northcoast | Neutral → Buy |
| Jun-12-15 | Downgrade | Raymond James | Strong Buy → Outperform |
| May-07-13 | Downgrade | Griffin Securities | Buy → Hold |
| Feb-08-13 | Reiterated | Griffin Securities | Buy |
| Aug-03-12 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Feb-08-12 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-03-11 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-09-11 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-21-10 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-17-10 | Initiated | JMP Securities | Mkt Outperform |
| Apr-07-10 | Reiterated | CL King | Strong Buy |
| Mar-26-10 | Initiated | CL King | Strong Buy |
| Mar-03-10 | Initiated | Brean Murray | Hold |
View All
Steris Plc Stock (STE) Latest News
Steris plc stock (IE00BFY8C754): solid earnings momentum and upcoming dividend date - AD HOC NEWS
STERIS Plc (STE) Stock Analysis: Unveiling A Promising 18.60% Upside Potential - DirectorsTalk Interviews
Swedbank AB Has $68.72 Million Position in STERIS plc $STE - MarketBeat
Life Cycle Investment Partners Ltd Takes Position in STERIS plc $STE - MarketBeat
Steris PLC stock underperforms Friday when compared to competitors - MarketWatch
Reasons to Retain STE Stock in Your Portfolio for Now - TradingView
STE Stock Price, Quote & Chart | STERIS PLC (NYSE:STE) - ChartMill
Steris PLC stock outperforms competitors on strong trading day - MarketWatch
Piper Sandler reiterates Overweight on Steris stock at $270 target By Investing.com - Investing.com Australia
Piper Sandler reiterates Overweight on Steris stock at $270 target - Investing.com
STERIS plc $STE Stock Holdings Boosted by Handelsbanken Fonder AB - MarketBeat
Steris stock (IE00BFY8C754): steady after latest quarterly results and acquisition push - AD HOC NEWS
Steris plc stock (IE00BFY8C754): earnings momentum and NYSE move put infection prevention specialist - AD HOC NEWS
Premier Fund Managers Ltd's Steris PLC(STE) Holding History - GuruFocus
Steris plc stock (IE00BFY8C754): solid earnings momentum and infection-control demand - AD HOC NEWS
The 5 Most Interesting Analyst Questions From STERIS’s Q1 Earnings Call - Yahoo Finance
Steris stock (IE00BFY8C754): earnings update and long-term hygiene demand - AD HOC NEWS
STERIS Plc (STE) Stock Analysis: Healthcare Giant With 21% Upside Potential - DirectorsTalk Interviews
Steris anticipates 7%-8% revenue growth and $11.10-$11.30 EPS in fiscal 2027 as board authorizes $1B buyback - MSN
Steris plc stock (IE00BFY8C754): Revenue momentum and analyst targets stay in focus - AD HOC NEWS
Q1 Earnings Highs And Lows: STERIS (NYSE:STE) Vs The Rest Of The Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
STERIS plc stock (US8589121081): Institutional buying highlights infection-prevention specialist - AD HOC NEWS
Dana Investment Advisors Inc. Acquires 39,753 Shares of STERIS plc $STE - MarketBeat
Number of shareholders of STERIS plc (Ireland) – NYSE:STE - TradingView
Steris PLC stock outperforms competitors despite losses on the day - MarketWatch
Sterilization Technology Market Is Going to Boom |• Steris Corporation • 3M Company • Getinge AB - openPR.com
STERIS Q4 Earnings Call Highlights - MarketBeat
Steris plc stock (IE00BFY8C754): steady growth story after latest earnings - AD HOC NEWS
Earnings call transcript: STERIS Q4 2026 sees strong revenue, EPS miss - Investing.com India
Earnings call transcript: STERIS Q4 2026 sees strong revenue, EPS miss By Investing.com - Investing.com South Africa
How Investors May Respond To STERIS (STE) Record FY26 Results And US$1 Billion Buyback Plan - simplywall.st
New STERIS (STE) director Pierre Boulud files initial Form 3 ownership report - Stock Titan
Steris bets big on Mentor with new $60M plant and U.S. consolidation plan - Crain's Cleveland Business
Steris plc stock (IE00BFY8C754): Shares up 1.41% to $230.46 on Jul 25 - AD HOC NEWS
A Look At STERIS (STE) Valuation After Recent Share Price Weakness - Yahoo Finance
Steris stock (IE00BFY8C754): Q4 earnings miss, analyst targets cut - AD HOC NEWS
STE Maintained by Keybanc -- Price Target Lowered to $269 - GuruFocus
KeyBanc cuts STERIS stock price target on lower peer multiples - Investing.com
KeyBanc cuts STERIS stock price target on lower peer multiples By Investing.com - Investing.com Nigeria
Stephens Adjusts Price Target on STERIS to $270 From $300, Maintains Overweight Rating - marketscreener.com
Jefferies Adjusts Price Target on STERIS to $225 From $253, Maintains Hold Rating - marketscreener.com
KeyBanc Adjusts Price Target on STERIS to $269 From $291, Maintains Overweight Rating - marketscreener.com
Piper Sandler Adjusts Price Target on STERIS to $270 From $300, Maintains Overweight Rating - Moomoo
Steris stock (IE00BFY8C754): Q4 revenue beats but EPS misses guidance - AD HOC NEWS
KeyBanc Maintains Steris PLC(STE.US) With Buy Rating, Cuts Target Price to $269 - Moomoo
Needham Maintains Steris PLC(STE.US) With Hold Rating - Moomoo
What To Expect From STERIS’s (STE) Q1 Earnings - Yahoo Finance UK
Steris Earnings: Sensible Share Buyback Plan and Promising Guidance for Fiscal 2027; FVE Increased - Morningstar
Higher Near-Term Revenue Forecasts and Expanding Margins Lift Steris' Fair Value Estimate - Morningstar
Steris PLC (STE) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook By GuruFocus - Investing.com Canada
STERIS Plc Experiences Valuation Adjustment Amid Competitive Pharmaceuticals Landscape - Markets Mojo
Steris Plc Stock (STE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):